National and Kapodistrian University of Athens
Investigation of the role of microglial cells in the progression of the sporadic form of Alzheimer's disease
Abstract
dc:descriptionAlzheimer’s disease (AD) is the most prevalent type of dementia and causes a progres¬sive loss of cognition, for which there is not an effective treatment or cure. Τhere are evidence indicating an important role of neuroinflammation and microglia activation, as well as genetic susceptibility in AD pathogenesis. Recent genome-wide association studies have identified key genetic risk variants, with Bridging Integrator 1 (BIN1), which is highly expressed in microglia, to constitute the second strongest genetic risk factor for late onset AD (LOAD) after apolipoprotein E (APOE). While neuronal BIN1 has been extensively studied and linked to synaptic dysfunction, altered calcium signaling, tau pathology, and neuronal hyperexcitability, the specific role of microglial BIN1 in AD progression remains underexplored, with recent evidence indicating that BIN1 contributes in microglia’s proinflammatory and disease-associated activation states. To this end, we have developed a conditional double transgenic Cx3cr1CreER/+Bin1fl/fl mouse, in which Bin1 is conditionally knocked-out in microglia, and challenged the system with systemic lipopolysaccharide (LPS) administration, to investigate the effect of microglia BIN1 deletion under homeostatic and inflammatory conditions. Single nucleus transcriptome (snRNA Seq) of mouse cortices revealed that, microglial BIN1 deletion is not sufficient to cause significant changes under homeostatic conditions, nevertheless, neuroinflammation elicits upregulation of key genes controlling microglial proliferation (Mki67, Top2a, Knl1, Cenpp) as well as inflammatory response (Stat1, Ifi204, Ifi30, Ptprc). Moreover, gene ontology analysis confirmed enrichment in pathways related to immune responses, endocytosis, type I interferon production, and complement activation. Importantly, LPS induced a substantially stronger transcriptional response in Bin1cKO microglia compared to controls, suggesting that BIN1 deficiency “primes” microglia toward heightened inflammatory activation state. Microglia clustering analysis further identified distinct microglial subpopulations associated with BIN1 deficiency following neuroinflammation. Specifically, clusters enriched in Bin1cKO + LPS animals displayed strong transcriptional signatures of proliferating microglia and interferon-responsive microglia (IRMs), characterized by elevated expression of genes such as Top2a, Mki67, Ifi204, Irf7, Stat1, and Stat2. Furthermore, cell signature analyses demonstrated overlap with previously described disease-associated microglia (DAM) and activated response microglia (ARM) states, that are commonly observed in neurodegenerative disease and aging. These findings indicate that microglial BIN1 deletion promotes a transition toward activated and disease-associated inflammatory phenotypes in response to systemic inflammation. Subsequently, molecular and phenotypic analyses of mouse cortices further supported and confirmed the snRNA-Seq observations. As far as microglial proliferation is concerned, in vivo immunohistochemical analyses revealed significantly increased microglial proliferation in Bin1cKO mice following LPS administration. Concomitantly, morphometric analyses indicated that Bin1cKO even under homeostatic conditions is sufficient to alter microglia phenotype, with BIN1-deficient microglia adopting a hyper-ramified morphology, indicative of an intermediate activation state linked to acute and chronic stress, an effect that was further potentiated upon LPS administration. Additionally, there was an increased CD11c expression in Bin1cKO microglia in response neuroinflammation, further supporting the enhanced activated microglial response. Proteome analysis further supported that microglia Bin1cKO drives distinct inflammatory profiles under both homeostatic and LPS-stimulated conditions in mouse cortical area, with elevated levels of inflammatory cytokines and chemokines and with particularly strong induction following LPS stimulation. Notably, the type I interferon (IFN-I) pathway emerged as a major mediator of the enhanced inflammatory response. Key IFN-I regulators, including Stat1, Irf7, Ifi204, Ifi27l2a, and Oasl2, were significantly upregulated in Bin1cKO cortices following inflammation. Simultaneously, IFI204 protein expression was markedly elevated in microglia, supporting the establishment of an IFN-I-responsive inflammatory phenotype. Importantly, microglial BIN1 deletion also induced non-cell-autonomous effects on other glial populations. Astrocytes and oligodendrocytes displayed transcriptional signatures associated with reactive states, lipid metabolism and myelination. Furthermore, comparison of our sequencing data with human AD snRNA-seq datasets revealed that BIN1 expression is significantly reduced in microglia from individuals with AD during disease progression. Moreover, Bin1cKO and systemic inflammation recapitulate several transcriptomic features observed in early AD pathology, including shared trend of genes implicated in neurodegeneration, interferon signaling and DAM activation. Collectively, our study identifies a feed-forward LPS–BIN1 mechanism in which the loss of microglial BIN1 amplifies a proinflammatory signaling. These findings reveal that BIN1 has a more complex and context-dependent role in neuroinflammation than previously described. Systemic immune challenges disrupt normal microglial activity and may accelerate AD progression. We propose that microglial BIN1 functions as a molecular “gatekeeper,” where its deficiency establishes a "primed" basal state that predisposes the brain to an enhanced inflammatory cascade upon immune challenge that may be either beneficial or detrimental for human BIN1 risk carriers.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2026
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Margariti, Maria
- Μαργαρίτη, Μαρία
Subjects
dc:subject × 12Rights
- Language dc:language
- eng
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/62158